Jazz Pharma (JAZZ) Q2 Earnings & Revenues Miss, View Intact

9 Aug 2017 - Nasdaq
Jazz Pharmaceuticals Public Limited Company JAZZ reported second quarter 2017 earnings of 1 72 per share which missed the Zacks Consensus Estimate of 1 85 Adjusted earnings of 2 12 per share including stock based compensation expenses decreased 6 2 from the year ago figure Jazz
usx:enz

---

PDL BioPharma (PDLI) Q2 Earnings Beat, Revenues Rise Y/Y

7 Aug 2017 - Nasdaq
PDL BioPharma Inc PDLI reported earnings of 26 cents per share in the second quarter of 2017 surpassing both the Zacks Consensus Estimate and the year ago earnings of 9 cents per share The company generated total revenue of 143 8 million in the quarter significantly skyrocketing
usx:enz

---

Epizyme (EPZM) Incurs Narrower-than-Expected Loss in Q2

7 Aug 2017 - Yahoo News
Epizyme, Inc. (EPZM) posted narrower-than-expected loss in Q2 as the company focuses on the development of tazemetostat.
usx:enz

---